Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Search

Page Path
HOME > Search
3 "Hyun-Jin Kim"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Special Articles
The Cancer Clinical Library Database (CCLD) from the Korea-Clinical Data Utilization Network for Research Excellence (K-CURE) Project
Sangwon Lee, Yeon Ho Choi, Hak Min Kim, Min Ah Hong, Phillip Park, In Hae Kwak, Ye Ji Kang, Kui Son Choi, Hyun-Joo Kong, Hyosung Cha, Hyun-Jin Kim, Kwang Sun Ryu, Young Sang Jeon, Hwanhee Kim, Jip Min Jung, Jeong-Soo Im, Heejung Chae
Received February 27, 2024  Accepted July 9, 2024  Published online July 15, 2024  
DOI: https://doi.org/10.4143/crt.2024.218    [Epub ahead of print]
AbstractAbstract PDFPubReaderePub
The common data model (CDM) has found widespread application in healthcare studies, but its utilization in cancer research has been limited. This article describes the development and implementation strategy for Cancer Clinical Library Databases (CCLDs), which are standardized cancer-specific databases established under the Korea-Clinical Data Utilization Network for Research Excellence (K-CURE) project by the Korean Ministry of Health and Welfare. Fifteen leading hospitals and fourteen academic associations in Korea are engaged in constructing CCLDs for 10 primary cancer types. For each cancer type-specific CCLD, cancer data experts determine key clinical data items essential for cancer research, standardize these items across cancer types, and create a standardized schema. Comprehensive clinical records covering diagnosis, treatment, and outcomes, with annual updates, are collected for each cancer patient in the target population, and quality control is based on six-sigma standards. To protect patient privacy, CCLDs follow stringent data security guidelines by pseudonymizing personal identification information and operating within a closed analysis environment. Researchers can apply for access to CCLD data through the K-CURE portal, which is subject to Institutional Review Board and Data Review Board approval. The CCLD is considered a pioneering standardized cancer-specific database, significantly representing Korea’s cancer data. It is expected to overcome limitations of previous CDMs and provide a valuable resource for multicenter cancer research in Korea.
  • 1,276 View
  • 89 Download
Close layer
Data Resource Profile: The Cancer Public Library Database in South Korea
Dong-Woo Choi, Min Yeong Guk, Hye Ri Kim, Kwang Sun Ryu, Hyun-Joo Kong, Hyo Soung Cha, Hyun-Jin Kim, Heejung Chae, Young Sang Jeon, Hwanhee Kim, Jipmin Jung, Jeong-Soo Im, Kui Son Choi
Cancer Res Treat. 2024;56(4):1014-1026.   Published online April 30, 2024
DOI: https://doi.org/10.4143/crt.2024.207
AbstractAbstract PDFSupplementary MaterialPubReaderePub
This paper provides a comprehensive overview of the Cancer Public Library Database (CPLD), established under the Korean Clinical Data Utilization for Research Excellence project (K-CURE). The CPLD links data from four major population-based public sources: the Korea National Cancer Incidence Database in the Korea Central Cancer Registry, cause-of-death data in Statistics Korea, the National Health Information Database in the National Health Insurance Service, and the National Health Insurance Research Database in the Health Insurance Review & Assessment Service. These databases are linked using an encrypted resident registration number. The CPLD, established in 2022 and updated annually, comprises 1,983,499 men and women newly diagnosed with cancer between 2012 and 2019. It contains data on cancer registration and death, demographics, medical claims, general health checkups, and national cancer screening. The most common cancers among men in the CPLD were stomach (16.1%), lung (14.0%), colorectal (13.3%), prostate (9.6%), and liver (9.3%) cancers. The most common cancers among women were thyroid (20.4%), breast (16.6%), colorectal (9.0%), stomach (7.8%), and lung (6.2%) cancers. Among them, 571,285 died between 2012 and 2020 owing to cancer (89.2%) or other causes (10.8%). Upon approval, the CPLD is accessible to researchers through the K-CURE portal. The CPLD is a unique resource for diverse cancer research to investigate medical use before a cancer diagnosis, during initial diagnosis and treatment, and long-term follow-up. This offers expanded insight into healthcare delivery across the cancer continuum, from screening to end-of-life care.

Citations

Citations to this article as recorded by  
  • Risk Factors and Prevention of Stomach Cancer, Excluding Helicobacter pylori
    Seung-Woo Lee
    The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2024; 24(3): 243.     CrossRef
  • Prediction model for survival of younger patients with breast cancer using the breast cancer public staging database
    Ha Ye Jin Kang, Minsam Ko, Kwang Sun Ryu
    Scientific Reports.2024;[Epub]     CrossRef
  • 2,287 View
  • 193 Download
  • 2 Crossref
Close layer
Original Article
The Economic Burden of Breast Cancer in Korea from 2007-2010
Young Ae Kim, In-Hwan Oh, Seok-Jun Yoon, Hyun-Jin Kim, Hye-Young Seo, Eun-Jung Kim, Yo Han Lee, Jae Hun Jung
Cancer Res Treat. 2015;47(4):583-590.   Published online February 13, 2015
DOI: https://doi.org/10.4143/crt.2014.143
AbstractAbstract PDFPubReaderePub
Purpose
This study estimates the socioeconomic cost and burden for breast cancer patients in Korea between 2007 and 2010. Materials and Methods This study used a prevalence-based approach to estimate the cost of breast cancer. Breast cancer patients were defined as those who were hospitalized or have visited an outpatient clinic during the period from 2007 to 2010. The socioeconomic costs of breast cancer were subdivided into two costs: direct and indirect.
Results
From 2007 to 2010, the prevalence of treated breast cancer increased from 7.9% to 20.4%. The total socioeconomic costs incurred by breast cancer increased by approximately 40.7% from US $668.49 million in 2007 to US $940.75 million in 2010. The direct medical care costs for 2010 were 1.4 times greater (US $399.22 million) than for 2007 (US $278.71 million). The direct non-medical costs rose from US $50.69 million in 2007 to US $75.83 million in 2010, a 49.6% increase. Regarding the economic burden of breast cancer, the total indirect costs were US $339.09 million in 2007 and increased by 37.3% to US $465.70 million in 2010. In the sensitivity analysis, with the annual discount rate for each year ranging from 0%-5%, the costs increased 1.1-1.2 times. Conclusion Due to the growing incidence of breast cancer, the annual prevalence and related costs are increasing. We must strive to reduce the socioeconomic burden of breast cancer through preventive measures and early screening.

Citations

Citations to this article as recorded by  
  • Cost of illness of breast cancer in low- and middle-income countries: a systematic review
    Siew Wei Yeong, Sit Wai Lee, Siew Chin Ong
    Health Economics Review.2024;[Epub]     CrossRef
  • Therapy-related myeloid neoplasm in early breast cancer patients treated with adjuvant chemotherapy
    Ji Won Lee, Hoonji Oh, Ji Young You, Eun-Shin Lee, Jung Hyun Lee, Sung Eun Song, Nam Kwon Lee, Seung Pil Jung, Jung Seok An, Kyu Ran Cho, Cheol Yong Kim, Kyong Hwa Park
    European Journal of Cancer.2023; 191: 112952.     CrossRef
  • Economic burden of breast cancer: a case of Southern Iran
    Faride Sadat Jalali, Khosro Keshavarz, Mozhgan Seif, Majid Akrami, Abdosaleh Jafari, Ramin Ravangard
    Cost Effectiveness and Resource Allocation.2023;[Epub]     CrossRef
  • Economic burden of breast cancer in northern Serbia
    Marko Milovic, Tatjana Tamas, Veljko Crnobrnja, Milica Paut Kusturica
    Frontiers in Public Health.2023;[Epub]     CrossRef
  • Measuring Trends in the Socioeconomic Burden of Disease in Korea, 2007-2015
    Tae Eung Kim, Ru-Gyeom Lee, So-Youn Park, In-Hwan Oh
    Journal of Preventive Medicine and Public Health.2022; 55(1): 19.     CrossRef
  • The direct cost incurred by patients and caregivers in diagnosing and managing prostate cancer in Ghana
    Ebenezer Wiafe, Kofi Boamah Mensah, Kwaku Addai Arhin Appiah, Frasia Oosthuizen, Varsha Bangalee
    BMC Health Services Research.2022;[Epub]     CrossRef
  • Cost analysis of breast cancer: a comparison between private and public hospitals in Iran
    Abolhasan Afkar, Habib Jalilian, Abolghasem Pourreza, Habibeh Mir, Abdolhosein Emami Sigaroudi, Somayeh Heydari
    BMC Health Services Research.2021;[Epub]     CrossRef
  • The Economic Burden Associated with the Management of Different Stages of Breast Cancer: A Retrospective Cost of Illness Analysis in Saudi Arabia
    Ahmed Alghamdi, Bander Balkhi, Shahad Alqahtani, Hamoud Almotairi
    Healthcare.2021; 9(7): 907.     CrossRef
  • Direct Medical Costs for Stage-Specific Breast Cancer: A Retrospective Analysis
    Qais Alefan, Alaa Saadeh, Rami J Yaghan
    Breast Cancer Management.2020;[Epub]     CrossRef
  • Socioeconomic Burden of Cancer in Korea from 2011 to 2015
    Young Ae Kim, Ye-Rin Lee, Jeongjoo Park, In-Hwan Oh, Hoseob Kim, Seok-Jun Yoon, Keeho Park
    Cancer Research and Treatment.2020; 52(3): 896.     CrossRef
  • Structural and Molecular Docking Analytical Studies of the Predicted Ligand Binding Sites of Cadherin-1 in Cancer Prognostics


    Olalekan Olanrewaju Bakare, Adewale Oluwaseun Fadaka, Marshall Keyster, Ashley Pretorius
    Advances and Applications in Bioinformatics and Chemistry.2020; Volume 13: 1.     CrossRef
  • Influencing Factors of Transportation Costs regarding Healthcare Service Utilization in Korea
    Su Yeon Jang, Jeong Yeon Seon, In-Hwan Oh
    Journal of Korean Medical Science.2020;[Epub]     CrossRef
  • Measuring the Economic Burden of Disease and Injury in Korea, 2015
    Ye-Rin Lee, Bogeum Cho, Min-Woo Jo, Minsu Ock, Donghoon Lee, Doungkyu Lee, Moon Jung Kim, In-Hwan Oh
    Journal of Korean Medical Science.2019;[Epub]     CrossRef
  • Complementary medicine use and costs in patients with breast cancer who experienced treatment-related side effects: A cross-sectional survey in Korea
    Sola Han, Bo-Hyoung Jang, Hae Sun Suh, Deok-Sang Hwang
    Complementary Therapies in Medicine.2019; 44: 210.     CrossRef
  • Financial barriers related to breast cancer screening and treatment: A cross-sectional survey of women in Kenya
    Sujha Subramanian, Robai Gakunga, Madeleine Jones, Asaph Kinyanjui, Emily Ochieng’, Nancy Gikaara, Maluni, David Wata, Anne Korir, Zipporah Ali
    Journal of Cancer Policy.2019; 22: 100206.     CrossRef
  • The economic burden of rotavirus infection in South Korea from 2009 to 2012
    Kyung Suk Lee, Ye-Rin Lee, So-Youn Park, In-Hwan Oh, Donald R. Olson
    PLOS ONE.2018; 13(3): e0194120.     CrossRef
  • Household Costs of Breast Cancer Morbidity: An Empirical Assessment from Pakistan
    Hafiz Zahid Mahmood, Imran Hameed Khaliq, Zafar Iqbal Bhatti, Kimberly J. Wilson, Khalid Masood Gondal, Summaira Malik, Shakila Zaman
    SSRN Electronic Journal .2018;[Epub]     CrossRef
  • Comparative clinicopathological and cytomorphological analyses of peritoneal carcinomatosis associated with metastatic breast carcinoma and primary peritoneal/ovarian carcinoma in patients with a history of breast carcinoma
    Kiyong Na, Jung-Yun Lee, Ji-Youn Sung, Gun Min Kim, Ja Seung Koo, Hyun-Soo Kim
    Virchows Archiv.2018; 473(2): 165.     CrossRef
  • Breast Cancer Detection Using Infrared Thermal Imaging and a Deep Learning Model
    Sebastien Jean Mambou, Petra Maresova, Ondrej Krejcar, Ali Selamat, Kamil Kuca
    Sensors.2018; 18(9): 2799.     CrossRef
  • The effect of tamoxifen therapy on the endometrium and ovarian cyst formation in patients with breast cancer
    Seul Lee, Yun Hwa Kim, Seung Chul Kim, Jong Kil Joo, Dong Suh Seo, Ki Hyung Kim, Kyu Sup Lee
    Obstetrics & Gynecology Science.2018; 61(5): 615.     CrossRef
  • The human circadian clock from health to economics
    Bala S. C. Koritala, Selim Çakmaklı
    PsyCh Journal.2018; 7(4): 176.     CrossRef
  • Economic Burden for Lung Cancer Survivors in Urban China
    Xin Zhang, Shuai Liu, Yang Liu, Jian Du, Wenqi Fu, Xiaowen Zhao, Weidong Huang, Xianming Zhao, Guoxiang Liu, Zhengzhong Mao, Teh-wei Hu
    International Journal of Environmental Research and Public Health.2017; 14(3): 308.     CrossRef
  • Strategies for Appropriate Patient-centered Care to Decrease the Nationwide Cost of Cancers in Korea
    Jong-Myon Bae
    Journal of Preventive Medicine and Public Health.2017; 50(4): 217.     CrossRef
  • Productivity losses and public finance burden attributable to breast cancer in Poland, 2010–2014
    Błażej Łyszczarz, Ewelina Nojszewska
    BMC Cancer.2017;[Epub]     CrossRef
  • The Economic Burden of Otitis Media in Korea, 2012: A Nationally Representative Cross-Sectional Study
    Young-Eun Kim, Ye-Rin Lee, So-Youn Park, Kyung Suk Lee, In-Hwan Oh
    BioMed Research International.2016; 2016: 1.     CrossRef
  • The Burden of Cancer in Korea during 2012: Findings from a Prevalence-Based Approach
    Young-hoon Gong, Seok-Jun Yoon, Min-Woo Jo, Arim Kim, Young Ae Kim, Jihyun Yoon, Hyeyoung Seo, Dongwoo Kim
    Journal of Korean Medical Science.2016; 31(Suppl 2): S168.     CrossRef
  • 13,957 View
  • 188 Download
  • 26 Web of Science
  • 26 Crossref
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP